Pelthos Therapeutics PTHS
NYSE PTHS
$25.51 -1.15 (-4.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Shares Outstanding (Entity) (2022 - 2026)

Pelthos Therapeutics (PTHS) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.54 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.73 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 252.88 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 218.28 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 575.47 Mn
10 Pelthos Therapeutics 91.09 Mn 66.53 Mn 21.23 Mn 3.72 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.83 Mn
Dec 31, 2025 1.88 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 673,320.00
Mar 31, 2025 618,356.00
Dec 31, 2024 610,381.00
Sep 30, 2024 581,811.00
Jun 30, 2024 582,317.00
Mar 31, 2024 469,099.00
Dec 31, 2023 127,654.00
Sep 30, 2023 98,626.00
Jun 30, 2023 98,292.00
Mar 31, 2023 111,111.00
Dec 31, 2022 43,531.00